Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected almost 200 million people worldwide and led to approximately 4 million deaths as of August 2021. Despite successful vaccine development, treatment options are limited. A promising strategy to specifically target viral infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolksdorf, Beatrice, Nie, Chuanxiong, Niemeyer, Daniela, Röhrs, Viola, Berg, Johanna, Lauster, Daniel, Adler, Julia M., Haag, Rainer, Trimpert, Jakob, Kaufer, Benedikt, Drosten, Christian, Kurreck, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539227/
https://www.ncbi.nlm.nih.gov/pubmed/34696460
http://dx.doi.org/10.3390/v13102030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539227/
https://www.ncbi.nlm.nih.gov/pubmed/34696460
http://dx.doi.org/10.3390/v13102030

Ejemplares similares